Company profile

Neurolens

Vision care / devicesChallengingFounded 2012

Contoured-prism lenses treating headache and eyestrain from subtle eye misalignment.

About

Prescription contoured-prism lenses (plus the N3 eye-tracking measurement device) for headache/neck-pain/eyestrain linked to binocular misalignment. Late-stage/growth-backed.

HQ: Coppell, TX, USA

Funding

$67M round (Sep 2022) + $45M growth capital (Dec 2023); ~$126M total